BRCA-related cancer; hereditary breast and ovarian cancer

Main|Search|PHGKB

From Guideline Database

This database contains updated guidelines, policies and recommendations on genomic research and practice, as provided by professional organizations, federal advisory groups, expert panels and policy groups.

---

• Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.  
  Published 2014 ( U.S. Preventive Services Task Force)
• Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.  
  Published 2016 ( European Society for Medical Oncology (ESMO))
• Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients.  
  Published 2016 ( Associazione Italiana di Oncologia Medica (AIOM)) ( Societa Italiana Genetica Umana (SIGU)) ( Societa Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBioC)) ( Societa Italiana di Anatomia Patologica e Citologia Diagnostica - Italian Division of the International Academy of Pathology (SIAPEC-IAP))
• SEOM clinical guidelines in Hereditary Breast and ovarian cancer.  
  Published 2015 ( Sociedad Espanola de Oncologia Medica (SEOM))
• Clinical Practice Guideline for the prevention and early detection of breast and ovarian cancer in women from HBOC (hereditary breast and ovarian cancer) families.  
  Published 2015

more